ClinicalTrials.Veeva

Menu

The Effect of Cataract on Photoentrainment of the Circadian Rhythm in Humans (CIRCAT)

G

Glostrup University Hospital, Copenhagen

Status

Completed

Conditions

Cataract

Treatments

Procedure: Conventional Intra Ocular Lens (IOL)
Procedure: Yellow Intra Ocular Lens (IOL)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Cataract is globally the most common cause of blindness and in Denmark the operation with - 50.000 treatments per year - is the most common eye operation. The cause of cataract is growth and denaturation of the lens proteins. This leads to an increased absorption of blue light and increased light scatter. This may affect newly discovered cells in the retina that are involved in the regulation of the circadian rhythm. When the internal circadian rhythm is not synchronized with the external day and night a phase-shift occurs. Most people know of this discomfort as jet-lag, but the consequences may be much more severe such as heighten risk of cancer and cardiovascular disease.

The goal of this project is to study how the circadian regulating cells of the retina is affected by cataract and by the operation. Cataract patients are studied before and after the operation with questionnaires, hormone and activity measurements and with a specialized pupil measurement that measures the indirect response of the circadian regulating cells to blue light.

Results from this study aim to shed light on the regulatory mechanisms of the eye on the circadian rhythm and how these are affected by cataract. Furthermore, choice of intraocular lens is evaluated. This may have impact on clinical practise especially with regard to choice of intraocular lens and widened indications for cataract surgery.

Enrollment

76 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age related/senile bilateral cataract
  • Eligible for phaco-emulsification on both eyes

Exclusion criteria

  • Known eye disease other than cataract.
  • Known systemic disease, which may affect the retina (untreated hypertension, DM etc.)
  • Known systemic disease, which may affect the lens.
  • Known psychiatric disease.
  • Known sleep or circadian rhythm disorder, not caused by lowered blue light transmission by the lens.
  • Per- and post operative complications
  • Use of drugs that may affect the sleep.

For a subpopulation also:

  • Poor cooperation.
  • Severe refraction abnormalities.
  • Previous eye surgery
  • Nystagmus
  • Congenital or acquired abnormalities of: eye lids and eye area, cornea or iris.
  • Use of medicine that may affect the pupillary response.
  • Use of drugs that may affect the pupillary response.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

76 participants in 2 patient groups

Conventional Intra Ocular Lens (IOL)
Active Comparator group
Description:
Standard minimal incision cataract surgery by phacoemulsification and posterior intraocular lens implantation.
Treatment:
Procedure: Conventional Intra Ocular Lens (IOL)
Yellow Intra Ocular Lens (IOL)
Experimental group
Description:
Standard minimal incision cataract surgery by phacoemulsification and posterior intraocular lens implantation.
Treatment:
Procedure: Yellow Intra Ocular Lens (IOL)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems